Key facts
- It has raised $6.9M; the latest was Seed Round ($6.9M) in Sep 2025.
- Notable investors include Animoca Brands, Big Brain Holdings, YZi Labs, Mirana Ventures, Collab+Currency — 29 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 29 names
- ·Watchlist + deal alerts for BIO Protocol
- ·The full record, as it builds
Funding rounds
No funding rounds for BIO Protocol are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About BIO Protocol
Provider of decentralized science services intended for funding and coordinating biotech research. The company allows users to fund, develop, and govern tokenized scientific intellectual property from universities, companies, and researchers worldwide, enabling the biotech market to direct capital and talent to early-stage science, accelerate research, and commercialize innovations quickly.
- Sector
- Information Technology
- HQ
- Zug, NY, Switzerland
- Founded
- 2022
- Employees
- 31
- Website
- bio.xyz/
- Ownership
- Privately Held (backing)
BIO Protocol doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BIO Protocol shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BIO Protocol in its N-PORT filings yet. We sweep new filings monthly.